Version history

{
  "session_id": "sess_a7f528aa-20c4-409d-a8c3-e2662850e63d_task_66f1207e_recon",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "Skeptic critique for analysis a7f528aa-20c4-409d-a8c3-e2662850e63d: VEGF Family GWAS Signals and Cerebrovascular-Neuronal Coupling in AD Hippocampus\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Association of ten VEGF family genes with Alzheimer's disease endophenotypes at single cell level could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: vascular changes may be secondary to neurodegeneration rather than upstream drivers.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing VEGF-family genetic control of vascular-neuronal coupling in vulnerable hippocampal regions in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that VEGF, GWAS, VEGF- mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
  "tokens_used": "377",
  "persona_id": "persona-skeptic"
}